We are live on ! Find out more
CA

Cambridge Associates Portfolio holdings

AUM $6.27B
1-Year Est. Return 14.78%
This Fund
S&P 500
This Quarter Est. Return
-0.68%
1 Year Est. Return
+14.78%
3 Year Est. Return
+41.48%
5 Year Est. Return
+36.86%
10 Year Est. Return
+95.69%
AUM
$890M
AUM Growth
+$321M
Cap. Flow
+$333M
Cap. Flow %
37.37%
Top 10 Hldgs %
85.78%
Holding
29
New
2
Increased
13
Reduced
6
Closed
2
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWC icon
26
iShares MSCI Canada ETF
EWC
$6.13B
$422K 0.05%
14,793
VEU icon
27
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$355K 0.04%
+6,844
New +$371K
DBC icon
28
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
-85,308
Closed -$1.45M
IXUS icon
29
iShares Core MSCI Total International Stock ETF
IXUS
$58.3B
-43,733
Closed -$2.76M

Similar funds

Cambridge Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Cambridge Associates held 29 positions worth $890M, up 56% from $569M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Cambridge Associates deployed $333M of net new capital in Q2 2018, opening 2 new positions and adding to 13 existing holdings. Its largest new stake was Vanguard Russell 1000 ETF: 95,587 shares worth $11.9M.

On the sell side, the largest reduction was iShares MSCI South Africa ETF, an estimated $2.69M trimmed.

  • Cambridge Associates's largest Q2 2018 buy was Vanguard Russell 1000 ETF: 95,587 shares worth $11.9M.
  • Cambridge Associates added most to Vanguard FTSE Developed Markets ETF in Q2 2018, an estimated $86.8M increase.
  • Cambridge Associates's biggest Q2 2018 reduction was iShares MSCI South Africa ETF, cutting an estimated $2.69M.
  • Cambridge Associates fully exited iShares Core MSCI Total International Stock ETF in Q2 2018, selling an estimated $2.76M.
  • Cambridge Associates's ten largest holdings make up 86% of its $890M portfolio in Q2 2018.
  • Cambridge Associates opened 2 new positions and closed 2 in Q2 2018.
  • Cambridge Associates's portfolio value rose 56% quarter-over-quarter to $890M.

Based on Cambridge Associates's 13F filing for Q2 2018, filed 13 Aug 2018.